In vitro metabolic profiling of new synthetic cannabinoids, ADB-FUBIATA, AFUBIATA, CH-FUBIATA, and CH-PIATA
Author:
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00204-023-03605-1.pdf
Reference21 articles.
1. Akram H, Mokrysz C, Curran HV (2019) What are the psychological effects of using synthetic cannabinoids? A systematic review. J Psychopharmacol 33:271–283. https://doi.org/10.1177/0269881119826592
2. Andrews R, Jorge R, Christie R, Gallegos A (2022) From JWH-018 to OXIZIDS: structural evolution of synthetic cannabinoids in the European Union from 2008 to present day. Drug Test Anal. https://doi.org/10.1002/dta.3422
3. Apirakkan O, Gavrilović I, Cowan DA, Abbate V (2020) In vitro phase I metabolic profiling of the synthetic cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA. Chem Res Toxicol 33:1653–1664. https://doi.org/10.1021/acs.chemrestox.9b00466
4. Chimalakonda KC, Moran CL, Kennedy PD et al (2011) Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal Chem 83:6381–6388. https://doi.org/10.1021/ac201377m
5. Deventer MH, Van Uytfanghe K, Vinckier IMJ et al (2022) A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB-FUBIATA. Drug Test Anal 14:1639–1644. https://doi.org/10.1002/dta.3285
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3